0 false false false false false false false false false true false false false false false false No description of principal activity 2023-01-01 Sage Accounts Production Advanced 2023 - FRS102_2021 xbrli:pure xbrli:shares iso4217:GBP 08447211 2023-01-01 2023-12-31 08447211 2023-12-31 08447211 2022-12-31 08447211 2022-04-01 2022-12-31 08447211 2022-12-31 08447211 2022-03-31 08447211 bus:LeadAgentIfApplicable 2023-01-01 2023-12-31 08447211 bus:Director1 2023-01-01 2023-12-31 08447211 core:WithinOneYear 2023-12-31 08447211 core:WithinOneYear 2022-12-31 08447211 bus:Director1 2022-12-31 08447211 bus:Director1 2023-12-31 08447211 bus:Director1 2022-03-31 08447211 bus:Director1 2022-12-31 08447211 bus:Director1 2022-04-01 2022-12-31 08447211 bus:Micro-entities 2023-01-01 2023-12-31 08447211 bus:AuditExemptWithAccountantsReport 2023-01-01 2023-12-31 08447211 bus:FullAccounts 2023-01-01 2023-12-31 08447211 bus:SmallCompaniesRegimeForAccounts 2023-01-01 2023-12-31 08447211 bus:PrivateLimitedCompanyLtd 2023-01-01 2023-12-31
COMPANY REGISTRATION NUMBER: 08447211
London Neurology Associates Limited
Filleted Unaudited Financial Statements
31 December 2023
London Neurology Associates Limited
Financial Statements
Year ended 31 December 2023
Contents
Page
Chartered accountant's report to the director on the preparation of the unaudited statutory financial statements
1
Balance sheet and the notes to the financial statements
2
London Neurology Associates Limited
Chartered Accountant's Report to the Director on the Preparation of the Unaudited Statutory Financial Statements of London Neurology Associates Limited
Year ended 31 December 2023
In order to assist you to fulfil your duties under the Companies Act 2006, we have prepared for your approval the financial statements of London Neurology Associates Limited for the year ended 31 December 2023, which comprise the balance sheet and the notes to the financial statements from the company's accounting records and from information and explanations you have given us. As a practising member firm of the Institute of Chartered Accountants in England and Wales (ICAEW), we are subject to its ethical and other professional requirements which are detailed at www.icaew.com/en/membership/regulations-standards-and-guidance. This report is made solely to the director of London Neurology Associates Limited in accordance with the terms of our engagement letter dated 13 October 2022. Our work has been undertaken solely to prepare for your approval the financial statements of London Neurology Associates Limited and state those matters that we have agreed to state to you in this report in accordance with ICAEW Technical Release 07/16 AAF as detailed at www.icaew.com/compilation. To the fullest extent permitted by law, we do not accept or assume responsibility to anyone other than London Neurology Associates Limited and its director for our work or for this report.
It is your duty to ensure that London Neurology Associates Limited has kept adequate accounting records and to prepare statutory financial statements that give a true and fair view of the assets, liabilities, financial position and loss of London Neurology Associates Limited. You consider that London Neurology Associates Limited is exempt from the statutory audit requirement for the year. We have not been instructed to carry out an audit or a review of the financial statements of London Neurology Associates Limited. For this reason, we have not verified the accuracy or completeness of the accounting records or information and explanations you have given to us and we do not, therefore, express any opinion on the statutory financial statements.
MILLER DAVIES LLP Chartered accountants
A3 Broomsleigh Business Park Worsley Bridge Road London SE26 5BN
26 September 2024
London Neurology Associates Limited
Balance Sheet
31 December 2023
Period from
Year to
1 Apr 22 to
31 Dec 23
31 Dec 22
£
£
£
Current assets
25,502
39,274
Creditors: amounts falling due within one year
15,199
17,738
--------
--------
Net current assets
10,303
21,536
--------
--------
Total assets less current liabilities
10,303
21,536
Accruals and deferred income
1,560
1,560
--------
--------
8,743
19,976
--------
--------
Capital and reserves
8,743
19,976
-------
--------
Notes to the financial statements
1. Director's advances, credits and guarantees
During the year the director entered into the following advances and credits with the company:
2023
Balance brought forward
Advances/ (credits) to the director
Balance outstanding
£
£
£
Dr K Cikurel
( 17,919)
4,130
( 13,789)
--------
-------
--------
2022
Balance brought forward
Advances/ (credits) to the director
Balance outstanding
£
£
£
Dr K Cikurel
( 17,146)
( 773)
( 17,919)
--------
----
--------
For the year ending 31 December 2023 the company was entitled to exemption from audit under section 477 of the Companies Act 2006 relating to small companies.
Director's responsibilities:
- The members have not required the company to obtain an audit of its financial statements for the year in question in accordance with section 476 ;
- The director acknowledges her responsibilities for complying with the requirements of the Act with respect to accounting records and the preparation of financial statements .
These financial statements have been prepared in accordance with the micro-entity provisions and have been delivered in accordance with the provisions applicable to companies subject to the small companies regime.
These financial statements were approved by the board of directors and authorised for issue on 26 September 2024 , and are signed on behalf of the board by:
Dr K Cikurel
Director
Company registration number: 08447211
The company is a private company limited by shares, registered in England and Wales. The address of the registered office is A3 Broomsleigh Business Park, Worsley Bridge Road, London, SE26 5BN.